Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Budget

Congress Rejects President’s Proposals to Cut Health NIH Research Funds

Washington, DC, September 12, 2017 — Robert Pear reports in The New York Times that, back in March, when President Donald J. Trump released the first draft of his budget proposal for the coming fiscal year, he asked lawmakers for deep cuts to one of their favorite institutions, the National Institutes of Health (NIH) — part of a broad reordering of priorities, away from science and social spending, toward defense and border security.

Six months later, Congress has not only rejected the president’s NIH’s proposal, lawmakers from both parties have joined forces to increase spending on biomedical research — and have bragged about it. Continue reading

U.S. Senate Appropriations Advances Spending Bills; Would Fund Regional Innovation at $21 Million

Westerville, OH, July 30, 2017 ― Jason Rittenberg on July 27 reported on the State Science & Technology Institute (SSTI) news blog that

Over the past week, the U.S. Senate Committee on Appropriations has passed bills to fund commerce and science, transportation, energy and water and agriculture. Regional Innovation Strategies would be funded at $21 million, an increase of $4 million over FY 2017.

Other innovation proposals received mixed support, as the Senate cut $3.2 billion from commerce, justice and science funding and another $400 million from agriculture. Continue reading

Opinion: Former Merck CEO and Princeton University President Emeritus on ‘Trump’s War on Science Threatens U.S. Prosperity’

Princeton, NJ, July 6, 2017Roy Vagelos, retired Chairman and CEO of Merck & Co. and Chairman of the Board of Regeneron Pharmaceuticals, and Shirley Tilghman, President Emeritus of Princeton University and a professor of Molecular Biology and Public Affairs, published the following opinion piece in The Star-Ledger on June 6:

In the past 40 years, the U.S. has been the world leader in converting fundamental scientific discoveries into innovative new treatments for life-threatening disease.  New drugs, vaccines, and medical devices have improved human health and increased our lifespan.

In this time, the treatment of cardiovascular disease has been transformed, HIV medications have been developed that mean AIDS is no longer a death sentence, and within the last five years, revolutionary new drugs that work through the activation of the immune system are now successfully treating some forms of cancer. Continue reading

NJ Spotlight’s Explainer: Up Close Look at the Horizon Law That Helped Trigger a State Shutdown

Trenton, NJ, July 5, 2017 — Lilo H. Stainton today reports in NJ Spotlight that the new law regarding Horizon Blue Cross and Blue Shield that was at the center of the state’s shutdown this past weekend borrows elements from insurance overhauls in other states, but was shaped in the end by local priorities.

Sen. Joe Vitale, (D-Middlesex) who spearheaded the legislation, said the measure is modeled on a law Pennsylvania enacted more than a decade ago to establish a range of reserves for Blue Cross Blue Shield plans operating in that state.

Maryland, Michigan, and Rhode Island have also implemented regulations designed to control the level of surplus accumulated by these health insurance providers. Continue reading

SSTI: U.S. House Appropriations Bills Would Make Major Cuts to Innovation

Westerville, OH, July 1, 2017 ― Jason Rittenberg reports on the State Science & Technology Institute (SSTI) news blog that the U.S. House Appropriations Committee began releasing FY 2018 “markup” budget bills at the end of June, and the proposals would cut billions in non-defense spending.

EDA would lose $117 million in program funding, SBA’s entrepreneurial development programs would lose $34 million, NIST’s Manufacturing Extension Partnership would lose $30 million, and Energy’s ARPA-E would be eliminated, among other cuts. Continue reading

Opinion: Former Merck CEO and Princeton University President Emeritus on ‘Trump’s War on Science Threatens U.S. Prosperity’

Princeton, NJ, June 12, 2017Roy Vagelos, retired Chairman and CEO of Merck & Co. and Chairman of the Board of Regeneron Pharmaceuticals, and Shirley Tilghman, President Emeritus of Princeton University and a professor of Molecular Biology and Public Affairs, published the following opinion piece in The Star-Ledger on June 6:

In the past 40 years, the U.S. has been the world leader in converting fundamental scientific discoveries into innovative new treatments for life-threatening disease.  New drugs, vaccines, and medical devices have improved human health and increased our lifespan. Continue reading

Trump Proposed 2018 Budget Makes Heavy Cuts to Science Research

President Donald Trump

Washington, DC, June 5, 2017 — Ali Breland reports on The Hill that President Trump’s fiscal 2018 budget unveiled Tuesday proposes massive cuts for the National Science Foundation.

The plan would cut $776 million, an 11 percent reduction, from the foundation, which gives grants for non-medical research in science and engineering.

Mick Mulvaney, the director of the Office of Management and Budget, defended the proposal, accusing the foundation of wasteful spending. Continue reading

White House’s 2018 Budget Plan Would ‘Devastate’ R&D, Says AAAS CEO Rush Holt

Washington, DC, May 31, 2017 — The double-digit percentage cuts President Donald Trump is proposing in his fiscal 2018 budget plan for science and technology programs would “devastate America’s science and technology enterprise” and weaken the nation’s economic growth, Rush Holt, CEO of the American Association for the Advancement of Science (AAAS), said on May 22.

Pointing to the budget blueprint the White House delivered to Congress Tuesday, Holt said, the plan, if enacted, would make steep cuts to science and technology programs and “negatively affect our nation’s economy and public well-being.”

Holt, a former New Jersey Congressman, cited several agencies and programs facing particularly “severe” cuts. Continue reading

Christie Administration Releases 2017 Taxpayers’ Guide to Education Spending

Trenton, NJ, April 26, 2017 — The New Jersey Department of Education last month released the 2017 Taxpayers’ Guide to Education Spending.

“The annual spending guide is a tool designed to provide transparency to New Jerseyans about how schools spend their taxpayer dollars to educate students,” said Acting Education Commissioner Kimberley Harrington.

The Taxpayers’ Guide to Education Spending includes two types of total expenditures for school districts’ annual budgets: Continue reading

Trump Budget Proposes Deep Cuts to Medical Research and Health Care

Washington, DC, May 24, 2017 — Alison Kodjak and Rob Stein report on NPR that President Donald J. Trump’s proposed budget unveiled Tuesday doubles down on major cuts to biomedical research, programs to fight infectious disease outbreaks, health care for the poor, elderly and disabled, and prevention of HIV/AIDS.

The 2018 budget, which is entitled “A New Foundation for American Greatness,” restates the goals of the “skinny budget” the administration released in March, which was widely condemned by scientists and public health advocates. Continue reading